These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24848793)

  • 1. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.
    Eslamparast T; Zamani F; Hekmatdoost A; Sharafkhah M; Eghtesad S; Malekzadeh R; Poustchi H
    Br J Nutr; 2014 Aug; 112(3):438-45. PubMed ID: 24848793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.
    Asemi Z; Khorrami-Rad A; Alizadeh SA; Shakeri H; Esmaillzadeh A
    Clin Nutr; 2014 Apr; 33(2):198-203. PubMed ID: 23786900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial.
    Roshan H; Nikpayam O; Sedaghat M; Sohrab G
    Br J Nutr; 2018 Feb; 119(3):250-258. PubMed ID: 29307310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study.
    Li S; Guerin-Deremaux L; Pochat M; Wils D; Reifer C; Miller LE
    Appl Physiol Nutr Metab; 2010 Dec; 35(6):773-82. PubMed ID: 21164548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of synbiotic supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes: a randomised, double-blind, placebo-controlled trial.
    Ahmadi S; Jamilian M; Tajabadi-Ebrahimi M; Jafari P; Asemi Z
    Br J Nutr; 2016 Oct; 116(8):1394-1401. PubMed ID: 27681077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial.
    Rabiei S; Hedayati M; Rashidkhani B; Saadat N; Shakerhossini R
    J Diet Suppl; 2019; 16(3):294-306. PubMed ID: 29672196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial.
    Nabhani Z; Hezaveh SJG; Razmpoosh E; Asghari-Jafarabadi M; Gargari BP
    Diabetes Res Clin Pract; 2018 Apr; 138():149-157. PubMed ID: 29432772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
    Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
    Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
    Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I
    Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial.
    Zamani B; Farshbaf S; Golkar HR; Bahmani F; Asemi Z
    Br J Nutr; 2017 Apr; 117(8):1095-1102. PubMed ID: 28490394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Basafa-Roodi P; Jazayeri S; Hadi F; Paghaleh SJ; Khosravi-Darani K; Malakouti SK
    BMC Psychiatry; 2024 Oct; 24(1):669. PubMed ID: 39385189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
    Pal S; Khossousi A; Binns C; Dhaliwal S; Ellis V
    Br J Nutr; 2011 Jan; 105(1):90-100. PubMed ID: 20727237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recommendations to follow the Dietary Approaches to Stop Hypertension (DASH) diet v. usual dietary advice on childhood metabolic syndrome: a randomised cross-over clinical trial.
    Saneei P; Hashemipour M; Kelishadi R; Rajaei S; Esmaillzadeh A
    Br J Nutr; 2013 Dec; 110(12):2250-9. PubMed ID: 23773316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
    Aquilante CL; Kosmiski LA; Zineh I; Rome LC; Knutsen SD
    Pharmacotherapy; 2010 Mar; 30(3):236-47. PubMed ID: 20180607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals.
    Giacco R; Clemente G; Luongo D; Lasorella G; Fiume I; Brouns F; Bornet F; Patti L; Cipriano P; Rivellese AA; Riccardi G
    Clin Nutr; 2004 Jun; 23(3):331-40. PubMed ID: 15158296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome.
    Snel M; Sleddering MA; Pijl H; Nieuwenhuizen WF; Frölich M; Havekes LM; Romijn JA; Jazet IM
    Eur J Clin Nutr; 2010 Apr; 64(4):419-23. PubMed ID: 20179727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
    Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial.
    Karimi E; Moini A; Yaseri M; Shirzad N; Sepidarkish M; Hossein-Boroujerdi M; Hosseinzadeh-Attar MJ
    Br J Nutr; 2018 Feb; 119(4):398-406. PubMed ID: 29498342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.